307 related articles for article (PubMed ID: 28723793)
1. Prognostic value of neutrophil-to-lymphocyte ratio for nasopharyngeal carcinoma: A meta-analysis.
Yin J; Qin Y; Luo YK; Feng M; Lang JY
Medicine (Baltimore); 2017 Jul; 96(29):e7577. PubMed ID: 28723793
[TBL] [Abstract][Full Text] [Related]
2. Prognostic role of neutrophil-lymphocyte ratio in nasopharyngeal carcinoma: A meta-analysis.
Takenaka Y; Kitamura T; Oya R; Ashida N; Shimizu K; Takemura K; Yamamoto Y; Uno A
PLoS One; 2017; 12(7):e0181478. PubMed ID: 28715474
[TBL] [Abstract][Full Text] [Related]
3. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: A systematic review and meta-analysis.
Su L; Zhang M; Zhang W; Cai C; Hong J
Medicine (Baltimore); 2017 Mar; 96(11):e6364. PubMed ID: 28296774
[TBL] [Abstract][Full Text] [Related]
4. Prognostic value of pretreatment neutrophil-to-lymphocyte ratio in renal cell carcinoma: a systematic review and meta-analysis.
Shao Y; Wu B; Jia W; Zhang Z; Chen Q; Wang D
BMC Urol; 2020 Jul; 20(1):90. PubMed ID: 32631294
[TBL] [Abstract][Full Text] [Related]
5. Prognostic value of pretreatment C-reactive protein/albumin ratio in nasopharyngeal carcinoma: A meta-analysis of published literature.
Yang X; Liu H; He M; Liu M; Zhou G; Gong P; Ma J; Wang Q; Xiong W; Ren Z; Li X; Zhang X
Medicine (Baltimore); 2018 Jul; 97(30):e11574. PubMed ID: 30045284
[TBL] [Abstract][Full Text] [Related]
6. Systematic review and metanalysis of neutrophil to lymphocyte ratio and prognosis in patients with nasopharyngeal carcinoma.
Zhao W; Li X; Lv L; Sun X; Xue J; Yang P; Tang J; Lv X
Laryngoscope Investig Otolaryngol; 2023 Dec; 8(6):1522-1531. PubMed ID: 38130245
[TBL] [Abstract][Full Text] [Related]
7. Neutrophil-to-lymphocyte ratio as a prognostic marker in locally advanced nasopharyngeal carcinoma: A pooled analysis of two randomised controlled trials.
Chua ML; Tan SH; Kusumawidjaja G; Shwe MT; Cheah SL; Fong KW; Soong YL; Wee JT; Tan TW
Eur J Cancer; 2016 Nov; 67():119-129. PubMed ID: 27640138
[TBL] [Abstract][Full Text] [Related]
8. Association of the neutrophil to lymphocyte ratio and clinical outcomes in patients with lung cancer receiving immunotherapy: a meta-analysis.
Jin J; Yang L; Liu D; Li W
BMJ Open; 2020 Jun; 10(6):e035031. PubMed ID: 32499266
[TBL] [Abstract][Full Text] [Related]
9. Prognostic significance of neutrophil-to-lymphocyte ratio in non-small cell lung cancer: a meta-analysis.
Gu XB; Tian T; Tian XJ; Zhang XJ
Sci Rep; 2015 Jul; 5():12493. PubMed ID: 26205001
[TBL] [Abstract][Full Text] [Related]
10. Prognostic value of neutrophil-to-lymphocyte ratio in advanced nasopharyngeal carcinoma: a large institution-based cohort study from an endemic area.
Yao JJ; Zhu FT; Dong J; Liang ZB; Yang LW; Chen SY; Zhang WJ; Lawrence WR; Zhang F; Wang SY; Sun Y; Zhou GQ
BMC Cancer; 2019 Jan; 19(1):37. PubMed ID: 30621619
[TBL] [Abstract][Full Text] [Related]
11. The clinicopathological and prognostic value of the pretreatment neutrophil-to-lymphocyte ratio in small cell lung cancer: A meta-analysis.
Lu Y; Jiang J; Ren C
PLoS One; 2020; 15(4):e0230979. PubMed ID: 32241019
[TBL] [Abstract][Full Text] [Related]
12. The prognostic value of before treatment neutrophil-to-lymphocyte ratio in nasopharyngeal carcinoma.
Song S; Chen H; Dou X; Wang K; Yan J; Yu C
Eur Arch Otorhinolaryngol; 2022 May; 279(5):2485-2492. PubMed ID: 34510259
[TBL] [Abstract][Full Text] [Related]
13. Prognostic value of post-radiotherapy neutrophil-to-lymphocyte ratio in locally advanced nasopharyngeal carcinoma.
Ou D; Wang X; Wu M; Xue F; Li Y; Hu C; He X
Strahlenther Onkol; 2020 Mar; 196(3):252-261. PubMed ID: 31701168
[TBL] [Abstract][Full Text] [Related]
14. Prognostic significance of neutrophil-to-lymphocyte ratio in diffuse large B-cell lymphoma: A meta-analysis.
Wang J; Zhou X; Liu Y; Li Z; Li X
PLoS One; 2017; 12(4):e0176008. PubMed ID: 28441396
[TBL] [Abstract][Full Text] [Related]
15. Neutrophil-to-Lymphocyte Ratio as a Prognostic Biomarker for Patients With Metastatic Renal Cell Carcinoma Treated With Immune Checkpoint Inhibitors: A Systematic Review and Meta-Analysis.
Chen X; Meng F; Jiang R
Front Oncol; 2021; 11():746976. PubMed ID: 34900692
[TBL] [Abstract][Full Text] [Related]
16. Pretreatment neutrophil to lymphocyte ratio in determining the prognosis of head and neck cancer: a meta-analysis.
Yu Y; Wang H; Yan A; Wang H; Li X; Liu J; Li W
BMC Cancer; 2018 Apr; 18(1):383. PubMed ID: 29618336
[TBL] [Abstract][Full Text] [Related]
17. Prognostic Significance of Neutrophil to Lymphocyte Ratio, Lymphocyte to Monocyte Ratio, and Platelet to Lymphocyte Ratio in Patients with Nasopharyngeal Carcinoma.
Lu A; Li H; Zheng Y; Tang M; Li J; Wu H; Zhong W; Gao J; Ou N; Cai Y
Biomed Res Int; 2017; 2017():3047802. PubMed ID: 28321405
[TBL] [Abstract][Full Text] [Related]
18. Prognostic significance of pretreatment neutrophil-to-lymphocyte ratio in patients with laryngeal cancer: a systematic review and meta-analysis.
Yang F; Huang Q; Guan Z; Diao Q
Eur Arch Otorhinolaryngol; 2021 Feb; 278(2):417-425. PubMed ID: 32886184
[TBL] [Abstract][Full Text] [Related]
19. Prognostic role of pretreatment blood neutrophil-to-lymphocyte ratio in advanced cancer survivors: A systematic review and meta-analysis of 66 cohort studies.
Mei Z; Shi L; Wang B; Yang J; Xiao Z; Du P; Wang Q; Yang W
Cancer Treat Rev; 2017 Jul; 58():1-13. PubMed ID: 28602879
[TBL] [Abstract][Full Text] [Related]
20. Pretreatment hematologic markers as prognostic factors in patients with nasopharyngeal carcinoma: Neutrophil-lymphocyte ratio and platelet-lymphocyte ratio.
Sun W; Zhang L; Luo M; Hu G; Mei Q; Liu D; Long G; Hu G
Head Neck; 2016 Apr; 38 Suppl 1():E1332-40. PubMed ID: 26362911
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]